Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Vähäsalo P[au]:

Haploinsufficiency of A20 impairs protein-protein interactome and leads into caspase-8-dependent enhancement of NLRP3 inflammasome activation. Rajamäki K et al. RMD Open. (2018)

[Chronic nonbacterial osteomyelitis]. Keskitalo P et al. Duodecim. (2016)

Gut microbiota-host interactions and juvenile idiopathic arthritis. Arvonen M et al. Pediatr Rheumatol Online J. (2016)

Search results

Items: 1 to 50 of 60

1.

Longitudinal Pattern of First-Phase Insulin Response Is Associated with Genetic Variants Outside the Class II HLA Region in Children with Multiple Autoantibodies.

Koskinen MK, Mikk ML, Laine AP, Lempainen J, Löyttyniemi E, Vähäsalo P, Hekkala A, Härkönen T, Kiviniemi M, Simell O, Knip M, Veijola R, Ilonen J, Toppari J.

Diabetes. 2019 Oct 7. pii: db190329. doi: 10.2337/db19-0329. [Epub ahead of print]

PMID:
31591105
2.

Defining new clinically derived criteria for high disease activity in non-systemic juvenile idiopathic arthritis: a Finnish multicentre study.

Backström M, Tynjälä P, Aalto K, Ylijoki H, Putto-Laurila A, Grönlund MM, Kärki J, Keskitalo P, Sard S, Pohjankoski H, Hietanen M, Witter S, Lehto H, Löyttyniemi E, Vähäsalo P.

Rheumatol Adv Pract. 2018 Oct 24;2(2):rky044. doi: 10.1093/rap/rky044. eCollection 2018.

3.

Efficacy and safety of tocilizumab in a real-life observational cohort of patients with polyarticular juvenile idiopathic arthritis.

Grönlund MM, Remes-Pakarinen T, Kröger L, Markula-Patjas K, Backström M, Putto-Laurila A, Aalto K, Vähäsalo P.

Rheumatology (Oxford). 2019 Jul 29. pii: kez291. doi: 10.1093/rheumatology/kez291. [Epub ahead of print]

PMID:
31359057
4.

Validating 10-joint juvenile arthritis disease activity score cut-offs for disease activity levels in non-systemic juvenile idiopathic arthritis.

Backström M, Tynjälä P, Aalto K, Grönlund MM, Ylijoki H, Putto-Laurila A, Kärki J, Keskitalo P, Sard S, Pohjankoski H, Hietanen M, Witter S, Lehto H, Löyttyniemi E, Vähäsalo P.

RMD Open. 2019 Apr 24;5(1):e000888. doi: 10.1136/rmdopen-2018-000888. eCollection 2019.

5.

The mortality rate and causes of death among juvenile idiopathic arthritis patients in Finland.

Kyllönen MS, Kautiainen H, Puolakka K, Vähäsalo P.

Clin Exp Rheumatol. 2019 May-Jun;37(3):508-511. Epub 2019 Feb 11.

PMID:
30767877
6.

Haploinsufficiency of A20 impairs protein-protein interactome and leads into caspase-8-dependent enhancement of NLRP3 inflammasome activation.

Rajamäki K, Keskitalo S, Seppänen M, Kuismin O, Vähäsalo P, Trotta L, Väänänen A, Glumoff V, Keskitalo P, Kaarteenaho R, Jartti A, Hautala N, Jackson P, Nordström DC, Saarela J, Hautala T, Eklund KK, Varjosalo M.

RMD Open. 2018 Oct 17;4(2):e000740. doi: 10.1136/rmdopen-2018-000740. eCollection 2018.

7.

The Finnish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Lahdenne P, Aalto K, Rebane K, Vahasalo P, Putto-Laurila AK, Malin M, Kroger L, Saila H, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Rheumatol Int. 2018 Apr;38(Suppl 1):179-186. doi: 10.1007/s00296-018-3950-3. Epub 2018 Apr 7.

8.

Cow's Milk Allergy in Infancy and Later Development of Juvenile Idiopathic Arthritis: A Register-Based Case-Control Study.

Arvonen M, Virta LJ, Pokka T, Kröger L, Vähäsalo P.

Am J Epidemiol. 2017 Jul 15;186(2):237-244. doi: 10.1093/aje/kwx060.

PMID:
28459985
9.

Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility.

Pöllänen PM, Lempainen J, Laine AP, Toppari J, Veijola R, Vähäsalo P, Ilonen J, Siljander H, Knip M.

Diabetologia. 2017 Jul;60(7):1284-1293. doi: 10.1007/s00125-017-4258-7. Epub 2017 Mar 31.

PMID:
28364254
10.

Gut microbiota-host interactions and juvenile idiopathic arthritis.

Arvonen M, Berntson L, Pokka T, Karttunen TJ, Vähäsalo P, Stoll ML.

Pediatr Rheumatol Online J. 2016 Jul 22;14(1):44. doi: 10.1186/s12969-016-0104-6. Review.

11.

[Chronic nonbacterial osteomyelitis].

Keskitalo P, Remes-Pakarinen T, Vähäsalo P, Niinimäki J, Kröger L.

Duodecim. 2016;132(2):145-51. Review. Finnish.

PMID:
26939487
12.

Faecal microbiome in new-onset juvenile idiopathic arthritis.

Tejesvi MV, Arvonen M, Kangas SM, Keskitalo PL, Pirttilä AM, Karttunen TJ, Vähäsalo P.

Eur J Clin Microbiol Infect Dis. 2016 Mar;35(3):363-70. doi: 10.1007/s10096-015-2548-x. Epub 2015 Dec 30.

PMID:
26718942
13.

Finding specific 10-joint Juvenile Arthritis Disease Activity Score (JADAS10) and clinical JADAS10 cut-off values for disease activity levels in non-systemic juvenile idiopathic arthritis: a Finnish multicentre study.

Backström M, Tynjälä P, Ylijoki H, Aalto K, Kärki J, Pohjankoski H, Keskitalo P, Sard S, Hietanen M, Lehto H, Kauko T, Vähäsalo P.

Rheumatology (Oxford). 2016 Apr;55(4):615-23. doi: 10.1093/rheumatology/kev353. Epub 2015 Oct 7. Review.

PMID:
26447164
14.

Occurrence of adverse events in patients with JIA receiving biologic agents: long-term follow-up in a real-life setting.

Tarkiainen M, Tynjälä P, Vähäsalo P, Lahdenne P.

Rheumatology (Oxford). 2015 Jul;54(7):1170-6. doi: 10.1093/rheumatology/keu457. Epub 2014 Dec 10.

PMID:
25504896
15.

Repeated exposure to antibiotics in infancy: a predisposing factor for juvenile idiopathic arthritis or a sign of this group's greater susceptibility to infections?

Arvonen M, Virta LJ, Pokka T, Kröger L, Vähäsalo P.

J Rheumatol. 2015 Mar;42(3):521-6. doi: 10.3899/jrheum.140348. Epub 2014 Oct 15.

PMID:
25320218
16.

[Still's disease--juvenile arthritis with systemic onset].

Kröger L, Putto-Laurila A, Vähäsalo P, Malin M, Aalto K.

Duodecim. 2014;130(16):1615-21. Review. Finnish.

PMID:
25269367
17.

Decreased expression of protease inhibitor 9, a granzyme B inhibitor, in celiac disease: a potential mechanism in enterocyte destruction and villous atrophy.

Pohjanen VM, Kokkonen TS, Arvonen M, Augustin MA, Patankar M, Turunen S, Vähäsalo P, Karttunen TJ.

Int J Immunopathol Pharmacol. 2013 Oct-Dec;26(4):897-905.

PMID:
24355225
18.

Altered expression of intestinal human leucocyte antigen D-related and immune signalling molecules in juvenile idiopathic arthritis.

Arvonen M, Vähäsalo P, Turunen S, Salo HM, Mäki M, Laurila K, Vaarala O, Karttunen TJ.

Clin Exp Immunol. 2012 Dec;170(3):266-73. doi: 10.1111/j.1365-2249.2012.04663.x.

19.

[Medical treatment of juvenile idiopathic arthritis].

Kröger L, Vähäsalo P, Tynjälä P, Aalto K, Säilä H, Malin M, Putto-Laurila A, Lahdenne P.

Duodecim. 2012;128(5):477-86. Review. Finnish.

PMID:
22486063
20.

Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicentre randomised open-label clinical trial.

Tynjälä P, Vähäsalo P, Tarkiainen M, Kröger L, Aalto K, Malin M, Putto-Laurila A, Honkanen V, Lahdenne P.

Ann Rheum Dis. 2011 Sep;70(9):1605-12. doi: 10.1136/ard.2010.143347. Epub 2011 May 28.

PMID:
21623000
21.

Occurrence of inflammatory bowel disease in four patients with juvenile idiopathic arthritis receiving etanercept or infliximab.

Tarkiainen M, Tynjälä P, Vähäsalo P, Lahdenne P.

Scand J Rheumatol. 2011 Mar;40(2):150-2. doi: 10.3109/03009742.2010.499878. Epub 2010 Sep 26. No abstract available.

PMID:
20868307
22.

Increase of duodenal and ileal mucosal cytotoxic lymphocytes in juvenile idiopathic arthritis.

Arvonen M, Ikni L, Augustin M, Karttunen TJ, Vähäsalo P.

Clin Exp Rheumatol. 2010 Jan-Feb;28(1):128-34.

PMID:
20346253
23.

Heat shock protein expression is low in intestinal mucosa in juvenile idiopathic arthritis: a defect in immunoregulation?

Arvonen M, Tikanmäki M, Vähäsalo P, Karttunen TJ.

Scand J Rheumatol. 2010 May;39(3):212-8. doi: 10.3109/03009740903390145.

PMID:
20141486
24.

Predictive characteristics of diabetes-associated autoantibodies among children with HLA-conferred disease susceptibility in the general population.

Siljander HT, Simell S, Hekkala A, Lähde J, Simell T, Vähäsalo P, Veijola R, Ilonen J, Simell O, Knip M.

Diabetes. 2009 Dec;58(12):2835-42. doi: 10.2337/db08-1305. Epub 2009 Sep 15.

25.

Drug survival of the first and second course of anti-tumour necrosis factor agents in juvenile idiopathic arthritis.

Tynjälä P, Vähäsalo P, Honkanen V, Lahdenne P.

Ann Rheum Dis. 2009 Apr;68(4):552-7. doi: 10.1136/ard.2007.087130. Epub 2008 May 8.

PMID:
18467515
26.

Intestinal immune activation in juvenile idiopathic arthritis and connective tissue disease.

Kokkonen J, Arvonen M, Vähäsalo P, Karttunen TJ.

Scand J Rheumatol. 2007 Sep-Oct;36(5):386-9.

PMID:
17963169
27.

Impact of anti-TNF treatment on growth in severe juvenile idiopathic arthritis.

Tynjälä P, Lahdenne P, Vähäsalo P, Kautiainen H, Honkanen V.

Ann Rheum Dis. 2006 Aug;65(8):1044-9. Epub 2006 Jan 31.

28.

Increased frequency of islet cell antibodies in unaffected brothers of children with type 1 diabetes.

Eskola V, Vähäsalo P, Akerblom HK, Knip M; Finnish ENDIT Study Group.

Horm Res. 2003;59(4):195-200.

PMID:
12649574
29.
30.

Enterovirus infections are associated with the induction of beta-cell autoimmunity in a prospective birth cohort study.

Salminen K, Sadeharju K, Lönnrot M, Vähäsalo P, Kupila A, Korhonen S, Ilonen J, Simell O, Knip M, Hyöty H.

J Med Virol. 2003 Jan;69(1):91-8.

PMID:
12436483
31.

No evidence of abnormal regulation of antibody response to coxsackievirus B4 antigen in prediabetic children.

Heino L, Lönnrot M, Knip M, Kupila A, Erkkilä S, Toivonen A, Vähäsalo P, Ilonen J, Simell O, Hyöty H.

Clin Exp Immunol. 2001 Dec;126(3):432-6.

32.

Dynamic pattern of disease-associated autoantibodies in siblings of children with type 1 diabetes: a population-based study.

Savola K, Läärä E, Vähäsalo P, Kulmala P, Akerblom HK, Knip M; Childhood Diabetes in Finland Study Group.

Diabetes. 2001 Nov;50(11):2625-32.

33.

Beta-cell autoimmunity, genetic susceptibility, and progression to type 1 diabetes in unaffected schoolchildren.

Kulmala P, Rahko J, Savola K, Vähäsalo P, Sjöroos M, Reunanen A, Ilonen J, Knip M.

Diabetes Care. 2001 Jan;24(1):171-3. No abstract available.

PMID:
11194225
34.

Genetic, autoimmune, and clinical characteristics of childhood- and adult-onset type 1 diabetes.

Sabbah E, Savola K, Ebeling T, Kulmala P, Vähäsalo P, Ilonen J, Salmela PI, Knip M.

Diabetes Care. 2000 Sep;23(9):1326-32.

35.

Stability of autoantibodies and their relation to genetic and metabolic markers of Type I diabetes in initially unaffected schoolchildren.

Kulmala P, Rahko J, Savola K, Vähäsalo P, Veijola R, Sjöroos M, Reunanen A, Ilonen J, Knip M.

Diabetologia. 2000 Apr;43(4):457-64.

PMID:
10819239
36.

Disease-associated autoantibodies as surrogate markers of type 1 diabetes in young children at increased genetic risk. Childhood Diabetes in Finland Study Group.

Kimpimäki T, Kulmala P, Savola K, Vähäsalo P, Reijonen H, Ilonen J, Akerblom HK, Knip M.

J Clin Endocrinol Metab. 2000 Mar;85(3):1126-32.

PMID:
10720050
37.

Glutamic acid decarboxylase and islet cell antibodies in healthy Estonian children.

Adojaan B, Sabbah E, Vähäsalo P, Akerblom HK, Podar T, Knip M.

J Pediatr Endocrinol Metab. 1999 Sep-Oct;12(5):667-72.

PMID:
10703539
38.

Genetic markers, humoral autoimmunity, and prediction of type 1 diabetes in siblings of affected children. Childhood Diabetes in Finland Study Group.

Kulmala P, Savola K, Reijonen H, Veijola R, Vähäsalo P, Karjalainen J, Tuomilehto-Wolf E, Ilonen J, Tuomilehto J, Akerblom HK, Knip M.

Diabetes. 2000 Jan;49(1):48-58.

PMID:
10615949
39.

Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. The Childhood Diabetes In Finland Study Group.

Sabbah E, Savola K, Kulmala P, Veijola R, Vähäsalo P, Karjalainen J, Akerblom HK, Knip M.

J Clin Endocrinol Metab. 1999 May;84(5):1534-9.

PMID:
10323375
40.

Disease-associated autoantibodies and HLA-DQB1 genotypes in children with newly diagnosed insulin-dependent diabetes mellitus (IDDM). The Childhood Diabetes in Finland Study Group.

Sabbah E, Savola K, Kulmala P, Reijonen H, Veijola R, Vähäsalo P, Karjalainen J, Ilonen J, Akerblom HK, Knip M.

Clin Exp Immunol. 1999 Apr;116(1):78-83.

41.

Autoantibodies associated with Type I diabetes mellitus persist after diagnosis in children.

Savola K, Sabbah E, Kulmala P, Vähäsalo P, Ilonen J, Knip M.

Diabetologia. 1998 Nov;41(11):1293-7.

PMID:
9833935
42.

Cow's milk consumption, disease-associated autoantibodies and type 1 diabetes mellitus: a follow-up study in siblings of diabetic children. Childhood Diabetes in Finland Study Group.

Virtanen SM, Hyppönen E, Läärä E, Vähäsalo P, Kulmala P, Savola K, Räsänen L, Aro A, Knip M, Akerblom HK.

Diabet Med. 1998 Sep;15(9):730-8.

PMID:
9737801
43.

Several different enterovirus serotypes can be associated with prediabetic autoimmune episodes and onset of overt IDDM. Childhood Diabetes in Finland (DiMe) Study Group.

Roivainen M, Knip M, Hyöty H, Kulmala P, Hiltunen M, Vähäsalo P, Hovi T, Akerblom HK.

J Med Virol. 1998 Sep;56(1):74-8.

PMID:
9700636
44.

Autoimmune and clinical characteristics of type I diabetes in children with different genetic risk loads defined by HLA-DQB1 alleles. Childhood Diabetes in Finland Study Group.

Komulainen J, Knip M, Sabbah E, Vähäsalo P, Lounamaa R, Akerblom HK, Reijonen H, Ilonen J.

Clin Sci (Lond). 1998 Mar;94(3):263-9.

PMID:
9616260
45.

IA-2 antibodies--a sensitive marker of IDDM with clinical onset in childhood and adolescence. Childhood Diabetes in Finland Study Group.

Savola K, Bonifacio E, Sabbah E, Kulmala P, Vähäsalo P, Karjalainen J, Tuomilehto-Wolf E, Meriläinen J, Akerblom HK, Knip M.

Diabetologia. 1998 Apr;41(4):424-9.

PMID:
9562346
46.

Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. The Childhood Diabetes in Finland Study Group.

Kulmala P, Savola K, Petersen JS, Vähäsalo P, Karjalainen J, Löppönen T, Dyrberg T, Akerblom HK, Knip M.

J Clin Invest. 1998 Jan 15;101(2):327-36.

47.
48.

Islet cell antibody seroconversion in children is temporally associated with enterovirus infections. Childhood Diabetes in Finland (DiMe) Study Group.

Hiltunen M, Hyöty H, Knip M, Ilonen J, Reijonen H, Vähäsalo P, Roivainen M, Lonnrot M, Leinikki P, Hovi T, Akerblom HK.

J Infect Dis. 1997 Mar;175(3):554-60.

PMID:
9041325
49.
50.

Supplemental Content

Loading ...
Support Center